Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

50%

2 of 4 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A

3(75.0%)

Phase 3

1(25.0%)

4Total

N/A(3)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials

NCT00116220Phase 3Completed

Study of External Beam Radiation Therapy With and Without Hormonal Therapy to Treat Prostate Cancer

Role: collaborator

NCT02084992Not ApplicableCompleted

A Study of a Technology-enabled Disease Management Program to Reduce Hospitalizations for Heart Failure

Role: collaborator

NCT01116882Not ApplicableCompleted

Percutaneous Coronary Intervention (PCI) Outcomes in Community Versus Tertiary Settings

Role: collaborator

NCT02072421Not ApplicableCompleted

The MASS COMM Post-Randomization Phase Cohort Study

Role: collaborator

NCT00681694Unknown

Long-Term Outcomes of Alternative Brachytherapy Techniques for Early Prostate Cancer

Role: collaborator

All 5 trials loaded